The simulations propose that IL-6 secreted by high-E2F1 melanoma cells is sufficient to trigger the activation of the IL-6/IL6R/STAT3 axis in CD4+ immune cells, which could also trigger secretion of other inflammatory factors. This evidence concerns the gene E2F1 and melanoma.